Senior insider sale
Chief Medical Officer at APOGEE THERAPEUTICS, INC. — senior position signals high conviction
$6.59M
53.90K shares
What this filing means
DAMBKOWSKI CARL plans to sell 53.90K shares of APOGEE THERAPEUTICS, INC. valued at approximately $6.59M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/1/2026ACC: 0001950047-26-006771
Officer· Chief Medical Officer
Since Mar 2026
53.90K
Shares to sell
$6.59M
Approx. market value
16.50K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months2
Exercise of Stock Options
Cash
7/1/2026
12.38KRestricted Stock Awards
N/A
12/14/2022
4.13KTotal acquired16.50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/1/2026 | Exercise of Stock Options Cash | 12.38K | — |
12/14/2022 | Restricted Stock Awards N/A | 4.13K | — |
| Total | 16.50K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
26.40K
Market value
$3.50M
6/22/2026
—Completed
Units to sell
5.50K
Market value
$432.9K
6/3/2026
—Completed
Units to sell
5.50K
Market value
$462.8K
5/6/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
16.50K
Market value
$2.19M
7/1/2026
Total
Units
53.90K
Value
$6.59M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/22/2026 | 26.40K | $3.50M | — | Completed |
6/3/2026 | 5.50K | $432.9K | — | Completed |
5/6/2026 | 5.50K | $462.8K | — | Completed |
| Planned — Approximate Date | ||||
7/1/2026 | 16.50K | $2.19M | NASDAQ | Planned |
| Total | 53.90K | $6.59M | ||